SMO Medical Technologies is a Site Management Organization — the recognized leader in clinical trial recruitment speed.
SMOMT manages a network of Research Sites and provides Sponsors and CROs with fast study start-up, predictable patient enrollment and centralized quality control.
We help reduce operational risks at every stage of the clinical trial: from feasibility assessment and Research Site activation to enrollment, monitoring and inspection readiness.
SMO Medical Technologies works with pharmaceutical and biotech companies, CROs, and research sites that require fast study start-up, predictable enrollment, transparent operations, and monitoring-ready sites.
The company supports international and local protocols across different phases, including Phase I–IV clinical trials, bioequivalence studies, pharmacokinetic and pharmacodynamic studies, post-marketing projects and specialized study designs.
A unified operational model helps control start-up, recruitment, documentation, monitoring and delivery quality across all Research Sites.
Who we support
Sponsors and CROs
We assess protocol feasibility, select Research Sites, organize patient recruitment and enrollment, control timelines and maintain delivery quality.
SMO Medical Technologies helps assess real enrollment potential, Research Site activation timelines and operational risks before study start. For Sponsors and CROs, this means less uncertainty before launch and more control during study delivery.
Research Sites
We take on the administrative and operational workload: documentation, training, communication, monitoring support and quality control.
The Research Site keeps its medical focus and patient care responsibilities, while SMO Medical Technologies supports operational processes: start-up preparation, Sponsor and CRO communication, monitoring support and unified working standards.
Patients and volunteers
We direct patients and volunteers to a separate patient-facing platform with open studies, participation requirements and coordinator contacts.
How we reduce study risks
Patient recruitment and enrollment
We assess the patient population in advance and use pre-screening, referral chains and detailed work with inclusion and exclusion criteria.
This means recruitment does not start from zero after Research Site activation — enrollment potential is evaluated before the study begins.
Research Site activation
We prepare Research Sites, Investigator Site File, teams, schedules and internal processes in parallel.
This approach helps shorten the time to First Patient First Visit and reduce start-up delays.
Data quality and monitoring readiness
We maintain unified SOPs, staff training, documentation control and monitoring readiness.
Regular monitoring preparation helps reduce the risk of deviations, repeated queries and open audit findings.
SMO Medical Technologies helps Sponsors and CROs solve key clinical trial challenges: patient recruitment limitations, study continuity risks and international Research Site expansion.
Recruitment geography expansion
Clinical trial continuity during COVID-19
International Research Site launch in Central Asia
Ready to discuss your clinical trial?
Tell us about your protocol, therapeutic area and expected timelines. SMO Medical Technologies will help assess recruitment potential, suitable Research Sites and the possible operational pathway for your study.
Submit request